## KDP: Keurig Dr Pepper Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 2.3% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($28.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Ossiam Increases Holdings in Keurig Dr Pepper, Inc $KDP**
- Source: MarketBeat | 20251209T130818 | Somewhat-Bullish | Relevance: 99%
-  Ossiam significantly increased its stake in Keurig Dr Pepper (NASDAQ:KDP) by 42.3% in Q2, acquiring 35,513 additional shares to reach a total of 119,462 shares valued at $3.95 million. This move is part of a broader trend of institutional investors boosting their holdings, with institutional ownership now at 93.99%. The company maintains a "Hold" consensus rating from Wall Street analysts, with a target price of $35.27, and recently reported strong quarterly revenues of $4.31 billion, surpassing estimates.

**2. Natixis Trims Stock Holdings in Keurig Dr Pepper, Inc $KDP**
- Source: MarketBeat | 20251210T115536 | Neutral | Relevance: 99%
-  Natixis reduced its stake in Keurig Dr Pepper (NASDAQ:KDP) by 41.6% in the second quarter, selling over 200,000 shares and retaining a holding valued at $9.59 million. Despite several Wall Street firms trimming price targets, the consensus rating for Keurig Dr Pepper remains a "Hold" with a target price of $35.27. The company recently reported quarterly EPS of $0.54, revenue of $4.31 billion, and announced a quarterly dividend of $0.23, representing a 3.2% yield.

**3. Keurig Dr Pepper, Inc $KDP Shares Purchased by Axa S.A.**
- Source: MarketBeat | 20251211T083459 | Neutral | Relevance: 99%
-  Axa S.A. increased its stake in Keurig Dr Pepper (KDP) by 24% in Q2, acquiring an additional 106,753 shares, bringing their total to 551,590 shares valued at $18.24 million. Keurig Dr Pepper reported Q3 EPS of $0.54 and revenue of $4.31 billion, along with announcing a quarterly dividend of $0.23 per share. Analysts currently hold a "Hold" rating on KDP with an average price target of $35.27.

**4. Keurig Dr Pepper Bolsters Investor Confidence with Latest Quarterly Dividend Declaration**
- Source: Markets Financial Content | 20251209T165800 | Bullish | Relevance: 98%
-  Keurig Dr Pepper (NASDAQ: KDP) has declared a regular quarterly cash dividend of $0.23 per share, payable on January 16, 2026, to shareholders of record as of January 2, 2026. This move highlights the company's financial stability and commitment to returning value to shareholders amidst a dynamic consumer beverage market. The consistent dividend payouts reinforce KDP's position as a reliable investment for long-term growth and income generation, signaling strong performance and effective management.

**5. Keurig Dr Pepper declares quarterly dividend of $0.23 per share By Investing.com**
- Source: Investing.com India | 20251209T213055 | Bullish | Relevance: 98%
- Keurig Dr Pepper (NASDAQ:KDP) announced a quarterly cash dividend of $0.23 per share, payable on January 16, 2026, to shareholders of record as of January 2, 2026. This marks the fifth consecutive year the company has raised its dividend, with an current annual yield of 3.17%. The company is a major North American beverage entity with a diverse portfolio of over 125 brands, generating annual revenue exceeding $15 billion.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 5 ($0.00M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (+0.1%)
- Capital World Invest: 8.2% (-12.1%)
- JPMORGAN CHASE & CO: 8.1% (+65.4%)
- Blackrock Inc.: 7.7% (-4.1%)
- FMR, LLC: 7.3% (-3.2%)

### Key Risks

1. Long-term trend broken: trading 5.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +1.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.63 indicates undervaluation relative to growth. Forward P/E 13.6x stretched relative to 6% growth. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $40.0B |
| Beta | 0.36 |
| 52W Range | $25.03 - $36.12 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.63 |
| Forward P/E | 13.6 |
| Current P/E | 14.4 |
| YoY Growth | 6.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.9% to 2.3% (+1.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >3.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. Outperforming sector by 3.4pp, stock-specific strength. Below SMA200 (0.94x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.31% (CS: 63) | Neutral |
| RSI_14 | 68.8 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.054x | Above |
| vs SMA50 | 1.080x | Above |
| vs SMA200 | 0.941x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $29.47
- **Stop Loss:** $28.29 (4.0% risk)
- **Target:** $30.65 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1169
- **Position Value:** $34,450.43
- **Portfolio %:** 34.45%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-24 (Est: $0.59)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.54 | $0.54 | +0.4% |
| 2025Q2 | $0.49 | $0.49 | +1.0% |
| 2025Q1 | $0.38 | $0.42 | +9.9% |
| 2024Q4 | $0.57 | $0.58 | +1.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*